U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928506) titled 'Effect of Hi-OxSR for the Treatment of Post COVID Condition (RECLAIM-HiOxSR)' on April 11.
Brief Summary: The RECLAIM study platform will be used to explore whether the use of the Hi-OxSR device improves the symptoms of post covid cognitive dysfunction. Carbon dioxide (CO2) has been proposed as a potential treatment for persistent immune activation as there is evidence that CO2 has antioxidant, anti-inflammatory, and anti-cytokine effects. We conducted a pilot study assessing the open label use of re-breathing CO2 (using Hi-OxSR) twice a day for 14 days, for the treatment of post-COVID cognitive dysfunction. Significant improvement...